...PIK3CA expression and Akt/mTOR activation, and PF-502 inhibited PI3K/mTORC1/2 targets. In human HNSCC expressing PIK3CA ...
...PIK3CA data were integrated with 17 previous reports (n = 5,594).,PIK3CA and PTEN mutations were identified in 11.9% and...
...PIK3CA-, HER2- and DDR2-aberrations) were performed and failed initially to detect any driver mutation. While the patien...
...PIK3CA oncogenes in a series of 280 CRC patients. MSI phenotypes are also considered in this series. All patients' clini...
...PIK3CA co-mutation, compared with KRAS wild-type controls. We show that, in the absence of PIK3CA co-mutation, KRAS muta...
...PIK3CA) inhibitor GDC-0941 to this treatment combination increases cell killing compared with double- or single-agent tr...
...PIK3CA and tumor suppressor genes p53, CDKN2A and NOTCH are discussed for their associations with HNSCC. Discussion of m...
...PIK3CA mutation (5%). No relationship was seen between PIK3CA, KRAS or BRAF mutation and local or distant recurrences.,T...
...PIK3CA mutations were sensitive to an mTOR/PI3K inhibitor (BEZ-235), in contrast to PIK3CA-wild-type tumorgrafts. These ...
...PIK3CA, and AKT1) have been documented in some patients. The large number of contributors for over more than a century a...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
